Could a ceramic barrier rebuild jawbone better than metal mesh?
NCT ID NCT07700095
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This trial tests whether custom-made 3D zirconia barriers can rebuild severely thinned jawbone better than the standard pre-bent titanium mesh. Sixteen people with significant bone loss in the lower jaw will receive one of the two materials during a first surgery, followed by dental implant placement later. The study measures changes in bone height, width, and volume, as well as infection and wound healing. Zirconia may offer better biocompatibility and easier removal than titanium.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- customized zirconia barrier
- What this could lead to
- If successful, this could offer a more biocompatible and easier-to-use alternative to titanium mesh for rebuilding jawbone, potentially improving dental implant success.
- What could go wrong
- This is a small early-stage trial with only 16 participants, so results may not apply broadly. Zirconia barriers could still cause infection or wound healing problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 16 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2024
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients are systemically medically free according to the American Society of Anesthesiologists (ASA) considered as ASA I. * Ability to maintain good oral hygiene as evidenced in recall visits. * patients who had a partial or completely edentulous alveolar ridge with apparent 3D defect following teeth loss. * All patients were free from any local or general disease that may interfere with bone healing and had no history of previous grafting procedure at the designated edentulous ridge. * The ridge had to exhibit severe vertical and horizontal (3D) alveolar ridge deficiency with alveolar ridge height less than 7 mm from the alveolar crest to the inferior alveolar canal and width less than 5 mm which was firstly measured by CBCT, or a clinically apparent increase in inter-arch space relative to the adjacent natural teeth. * Pre-operative clinical assessment of soft tissue coverage was done to cover the graft and its membrane, in addition to assessment of occlusion and inter-arch distance should allow for the graft, membrane, implan and the future prosthesis. Exclusion Criteria: * Smoker (\> 25 cigarettes/ day). * Patients undergoing radiotherapy or chemotherapy * Patients having infection or local lesions in the area of surgery. * Patients with diabetes mellitus or bone diseases which may compromise the results. * Patient with poor oral hygiene or active periodontal disease. * Patient with limited mouth opening. * Participation in other clinical trials
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mandibular atrophy are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kafr El-sheikh University
RECRUITINGKafr Elsheikh, Egypt